New research has cast doubt on whether today's advanced artificial intelligence models are truly capable of deep reasoning.

LeetCode is super important for coding interviews because lots of big tech companies use its style of problems. Getting good ...

Recursion Pharmaceuticals is now the sole owner of a drug in its pipeline. Shares in biotech company Recursion ...

Rallybio (NASDAQ:RLYB) stock soars 114% after agreeing to sell its stake in a rare bone disorder asset, extending cash runway to mid-2027. Read more here.

Rallybio has swerved away from its Recursion Pharmaceuticals pact, accepting $7.5 million upfront for its share of a preclinical program to extend its cash runway to mid-2027.

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of These 10 Stocks Are Making Big Moves. Recursion Pharmaceuticals ...

Rallybio has agreed to sell its interest in a drug-development plan seeking to treat a rare genetic bone disease to its joint-venture partner Recursion Pharmaceuticals for up to $25 million.

Using this information, the model can then tell us the probability of a drug-protein interaction that we did not previously ...

AI Oversight and the BBB. What the failed effort to pass a moratorium on AI legislation tells us, and what should states do ...

In this letter, a novel recursive total least squares (RTLS) algorithm that is grounded in a constrained Lagrange optimization of the errors-in-variables model is presented. The proposed RTLS method ...

In adaptive filters, several recursive algorithms have been used to track state-space model vectors in nonstationary environments. So far, kernel recursive algorithms showed the best results in this ...